Special Report
China’s Gan & Lee’s GZR18 Injection Achieves Up to 17.8% Weight Loss in Phase 2b Trial
Obese or overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean ...
November 12, 2024 | News
Ascletis' ASC47 Shows Promise in Phase I Trial with Once-Monthly Dosing and Superior Fat Reduction in Obesity Treatment
Data from a Phase I single ascending dose (SAD) study in Australia in subjects with elevated low-density lipoprotein cholesterol (LDL-C) showed...
November 08, 2024 | News
Powering Up Cartilage: New Mitochondrial Therapy Offers Fresh Hope for Osteoarthritis Patients
Researchers have discovered a promising new method for potentially treating osteoarthritis (OA), a debilitating joint disease for which there are currently...
November 08, 2024 | News
Minghui Pharmaceutical Announces Promising Phase I Results for MHB039A, a PD-1 x VEGF Bispecific Antibody, in Solid Tumor Treatment in China
Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company focused on developing transformative medicines in immunology and oncology, today annou...
November 07, 2024 | News
Breast Cancer Drug Shows Promise for Treating Hereditary Hemorrhagic Telangiectasia, a Rare Vascular Disorder
A drug commonly used to treat breast cancer might be able to help people living with hereditary hemorrhagic telangiectasia (HHT) – a rare genetic ble...
November 05, 2024 | News
AllazoHealth’s AI Personalization Boosts Therapy Initiation by 10.4% for Rare Disease Patients
AllazoHealth, a leader in AI-driven solutions for enhancing therapy initiation, adherence, and health outcomes, today announced the release of a compelling...
November 01, 2024 | News
Innovent's Picankibart Shows Promising Results in Phase 2 Trial for Psoriasis Patients Unresponsive to Previous Biologics
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
October 29, 2024 | News
Corvia Medical’s Atrial Shunt Demonstrates Long-Term Efficacy in Heart Failure Patients: Three-Year Trial Results Published
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced impressive three-year results from its REDUCE LAP-HF II ...
October 28, 2024 | News
Lunit AI Cuts Radiologist Workload by 50% While Predicting Cancer Risk Up to Six Years in Advance, New Studies Show
Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening qua...
October 24, 2024 | News
Minghui Pharmaceutical Reports Positive Results from Phase Ib/II Trial of MHB018A in Thyroid Eye Disease Patients
Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, ann...
October 23, 2024 | News
Why Singapore is the World’s New Pharma Powerhouse: Unpacking the Secrets Behind Its Manufacturing Boom
Singapore’s pharmaceutical revolution: How data and digital transformation are fueling a global hub Once primarily recognized for it...
October 22, 2024 | Opinion | By Venkatesh Arunachalam, General Manager of the Life Science Manufacturing group at Cognizant
Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation (HKBCF), launched its 16th annual research report&nbs...
September 30, 2024 | News
Cardiovascular Health Inequity for Women in the Asia-Pacific: A Call for Action
Kearney, a leading management consulting firm, has released a comprehensive report titled "Cardiovascular Health Inequity for Women in the Asia Pacif...
September 25, 2024 | Report
Australia Faces Urgent Call to Address Childhood Dementia Crisis in New 2024 Report
A groundbreaking new report, "State of Childhood Dementia in Australia 2024," released at Australia's Parliament House in Ca...
September 10, 2024 | Report
Most Read
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
